The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Topuzova M.P.

Almazov National Medical Research Centre

Ternovykh I.K.

Almazov National Medical Research Centre

Shustova T.A.

Almazov National Medical Research Centre

Mikheeva A.Yu.

Almazov National Medical Research Centre

Chistyakova A.O.

Almazov National Medical Research Centre

Pavlova T.A.

Almazov National Medical Research Centre

Dudnikova N.E.

Almazov National Medical Research Centre

Pospelova M.L.

Almazov National Medical Research Centre

Alekseeva T.M.

I.M. Sechenov First Moscow State Medical University

Multiple system atrophy

Authors:

Topuzova M.P., Ternovykh I.K., Shustova T.A., Mikheeva A.Yu., Chistyakova A.O., Pavlova T.A., Dudnikova N.E., Pospelova M.L., Alekseeva T.M.

More about the authors

Read: 7624 times


To cite this article:

Topuzova MP, Ternovykh IK, Shustova TA, et al. . Multiple system atrophy. S.S. Korsakov Journal of Neurology and Psychiatry. 2023;123(2):144‑150. (In Russ.)
https://doi.org/10.17116/jnevro2023123021144

Recommended articles:
Neuroimaging predictors of hemo­rrhagic transformation of ischemic stroke. S.S. Korsakov Journal of Neurology and Psychiatry. 2024;(12-2):34-38
Obstructive sleep apnea syndrome as a predictor of atrial fibrillation. Russian Journal of Preventive Medi­cine. 2025;(1):109-114
Virus-associated progesterone-resistant chro­nic endo­metritis — the onco­risk situation?. Russian Bulletin of Obstetrician-Gynecologist. 2025;(1):25-30
Modern approaches to cystic lung diseases diagnosis. Journal of Respiratory Medi­cine. 2025;(1):30-37
Primary bile acid synthesis diso­rders. Russian Journal of Evidence-Based Gastroenterology. 2025;(1):71-90

References:

  1. Graham JG, Oppenheimer DR. Orthostatic hypotension and nicotine sensitivity in a case of multiple system atrophy. Journal of Neurology, Neurosurgery, and Psychiatry. 1969;32(1):28-34.  https://doi.org/10.1136/jnnp.32.1.28
  2. Nguyen HHP, Cenci MA. Models of Multiple System Atrophy. Behavioral Neurobiology of Huntington’s Disease and Parkinson’s Disease 2015;22:369-393. 
  3. Rohrer G, Höglinger GU, Levin J. Symptomatic therapy of multiple system atrophy. Auton Neurosci. 2018;211:26-30.  https://doi.org/10.1016/j.autneu.2017.10.006
  4. Quinn N. Multiple system atrophy-the nature of the beast. Journal of Neurology, Neurosurgery, and Psychiatry. 1989;1:52(suppl):78-89.  https://doi.org/10.1136/jnnp.52.suppl.78
  5. Jellinger KA, Wenning GK. Multiple system atrophy: pathogenic mechanisms and biomarkers. Journal of Neural Transmission. 2016;123(6):555-572.  https://doi.org/10.1007/s00702-016-1545-2
  6. Palma JA, Norcliffe-Kaufmann L, Kaufmann H. Diagnosis of multiple system atrophy. Auton Neurosci. 2018;211:15-25.  https://doi.org/10.1016/j.autneu.2017.10.007
  7. Wenning GK. Multiple system atrophy. Autonomic Nervous System Volume. 2013;117:229-241. 
  8. Itoh K, Kasai T, Tsuji Y, et al. Definite familial multiple system atrophy with unknown genetics. Neuropathology. 2014;34(3):309-313.  https://doi.org/10.1111/neup.12092
  9. Multiple-System Atrophy Research Collaboration. Mutations in COQ2 in familial and sporadic multiple-system atrophy. N Engl J Med. 2013;369(3):233-244.  https://doi.org/10.1056/NEJMoa1212115
  10. Fanciulli A, Stankovic I, Krismer F, et al. Multiple system atrophy. Int Rev Neurobiol. 2019;149:137-192.  https://doi.org/10.1016/bs.irn.2019.10.004
  11. Heras-Garvin A, Stefanova N. MSA: From basic mechanisms to experimental therapeutics. Parkinsonism Relat Disord. 2020;73:94-104.  https://doi.org/10.1016/j.parkreldis.2020.01.010
  12. Yang F, Li WJ, Huang XS. Alpha-synuclein levels in patients with multiple system atrophy: a meta-analysis. Int J Neurosci. 2018;128(5):477-486.  https://doi.org/10.1080/00207454.2017.1394851
  13. Tison F, Yekhlef F, Chrysostome V, et al. Parkinsonism in multiple system atrophy: natural history, severity (UPDRS-III), and disability assessment compared with Parkinson’s disease. Mov Disord. 2002;17(4):701-709.  https://doi.org/10.1002/mds.10171
  14. Wenning GK, Geser F, Krismer F, et al; European Multiple System Atrophy Study Group. The natural history of multiple system atrophy: a prospective European cohort study. Lancet Neurol. 2013;12(3):264-274.  https://doi.org/10.1016/S1474-4422(12)70327-7
  15. Anderson T, Luxon L, Quinn N, et al. Oculomotor function in multiple system atrophy: clinical and laboratory features in 30 patients. Mov Disord. 2008;23(7):977-984.  https://doi.org/10.1002/mds.21999
  16. Jecmenica-Lukic M, Poewe W, Tolosa E, Wenning GK. Premotor signs and symptoms of multiple system atrophy. Lancet Neurol. 2012;11(4):361-368.  https://doi.org/10.1016/S1474-4422(12)70022-4
  17. Roncevic D, Palma JA, Martinez J, et al. Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival. J Neural Transm (Vienna). 2014;121(5):507-512.  https://doi.org/10.1007/s00702-013-1133-7
  18. Ershova MV, Akhmadullina DR, Fedotova EYu, Illarioshkin SN. Modern concepts of multisystem atrophy. Nervnye Bolezni. 2018;4:3-13. (In Russ.). https://doi.org/10.24411/2226-0757-2019-12051
  19. Wenning GK, Tison F, Ben Shlomo Y, et al. Multiple system atrophy: a review of 203 pathologically proven cases. Mov Disord. 1997;12(2):133-147.  https://doi.org/10.1002/mds.870120203
  20. Iranzo A. Sleep and breathing in multiple system atrophy. Curr Treat Options Neurol. 2007;9(5):347-353.  https://doi.org/10.1007/bf02938541
  21. Gilman S, Wenning GK, Low PA, et al. Second consensus statement on the diagnosis of multiple system atrophy. Neurology. 2008;71(9):670-676.  https://doi.org/10.1212/01.wnl.0000324625.00404.15
  22. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. J Neurol Neurosurg Psychiatry. 1992;55(3):181-184.  https://doi.org/10.1136/jnnp.55.3.181
  23. Golubev VL, Levin YaI, Vein AM. Bolezn’ Parkinsona i sindrom parkinsonizma. M.: MEDpress; 1999. (In Russ.).
  24. Demirkiran M, Bozdemir H, Sarica Y. Vascular parkinsonism: a distinct, heterogeneous clinical entity. Acta Neurol Scand. 2001;104(2):63-67.  https://doi.org/10.1034/j.1600-0404.2001.104002063.x
  25. Foltynie T, Barker R, Brayne C. Vascular parkinsonism: a review of the precision and frequency of the diagnosis. Neuroepidemiology. 2002;21(1):1-7.  https://doi.org/10.1159/000048607
  26. Rajput A, Rajput AH. Progressive supranuclear palsy: clinical features, pathophysiology and management. Drugs Aging. 2001;18(12):913-925.  https://doi.org/10.2165/00002512-200118120-00003
  27. Zhu S, Li H, Deng B, et al. Various Diseases and Clinical Heterogeneity Are Associated With «Hot Cross Bun». Front Aging Neurosci. 2020;12:34-39.  https://doi.org/10.3389/fnagi.2020.592212
  28. Storey E, Billimoria P. Increased T2 signal in the middle cerebellar peduncles on MRI is not specific for fragile X premutation syndrome. J Clin Neurosci. 2005;12(1):42-43.  https://doi.org/10.1016/j.jocn.2004.07.006
  29. Brunberg JA, Jacquemont S, Hagerman RJ, et al. Fragile X premutation carriers: characteristic MR imaging findings of adult male patients with progressive cerebellar and cognitive dysfunction. AJNR Am J Neuroradiol. 2002;23(10):1757-1766/
  30. Nikolaeva EA. Diagnostics and prevention of nuclear-encoded mitochondrial diseases in infants. Rossiyskiy Vestnik Perinatologii i Pediatrii. 2014;59(2):19-28. (In Russ.).

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.